NCT06192121Completed
Web-Based Education for Individuals With Type-2 Diabetes
The Effect of Self-Care Disability Theory-Based Web-Based Education for Individuals With Type-2 Diabetes on Care Outcomes
Source: ClinicalTrials.gov · Last updated 24 Jul 2024
Brief summary (registry, in English)
Type and Aim of Research This research will be conducted as a randomised controlled experimental study design to test the effect of web-based diabetes education on the quality of life and self-care activities of individuals with Type 2 Diabetes. Place and Time of the Study This research will be conducted between September 2023 and March 2024 with individuals registered to the Cyprus Turkish Diabetes Association. Population and Sample of the Study The population of the study consisted of individuals with Type-2 diabetes who applied to the Cyprus Turkish Diabetes Centre. The sample of the study included individuals with type-2 diabetes who met the inclusion criteria at the Turkish Cypriot Diabetes Centre. Sample size was calculated using G Power statistical programme (n=74). In order to evaluate the effectiveness in the experimental and control groups, simple randomisation was performed to ensure the similarity of the two groups. Randomisation was applied after the pre-tests. The data of the study will be collected by Sociodemographic Data Form, Diabetes Specific Quality of Life Scale, Diabetes Self-Care Activities Questionnaire, Website Analysis and Measurement Inventory. The forms will be applied to the participants face to face. People in the experimental group, whose information was sent to the researcher, will receive reminder messages twice a week (Wednesday-Friday) during the 3-month follow-up period via the website. No intervention will be applied to the control group. The post-test will be applied.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 80 (actual)
- First submitted
- 20 Dec 2023
- Start date
- 1 Sept 2023
- Primary completion date
- 1 Mar 2024
- Lead sponsor
- Near East University, Turkey
- Diseases
- Type 2 diabetes
- NCT number
- NCT06192121
What you commit to
- Study type: Interventional
- Participants enrolled: 80
- From 1 Sept 2023 to the primary completion date, 1 Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Working in the field of health and receiving health education in any field,
Other illness
- Those with Type 1 Diabetes
Age
- Under 18 years of age,
Other
- Cannot use a computer or smartphone,
- Individuals who participated in the preliminary application were not included in the study.
Who the study is looking for
- Having access to the Internet,
- Diagnosed with Type II Diabetes,
- Mentally competent,
- Individuals who volunteered to participate in the study were recruited.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Near East University Coordinator of this site? Confirm its status | Mersin | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.